Hao Duan

1.5k total citations
71 papers, 1.0k citations indexed

About

Hao Duan is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Hao Duan has authored 71 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 24 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Hao Duan's work include Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (9 papers) and Lung Cancer Research Studies (8 papers). Hao Duan is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (9 papers) and Lung Cancer Research Studies (8 papers). Hao Duan collaborates with scholars based in China, United States and Spain. Hao Duan's co-authors include Zhenqiang He, Yonggao Mou, Yanqing Gong, Yi Fan, Lin Zhang, Steven Brem, Haineng Xu, Qirui Wang, Zhenfeng Zhang and Menggui Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hao Duan

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Duan China 17 364 292 252 251 206 71 1.0k
Ryosuke Uchibori Japan 17 452 1.2× 288 1.0× 232 0.9× 120 0.5× 90 0.4× 27 915
Dejun Gong China 17 420 1.2× 286 1.0× 119 0.5× 177 0.7× 243 1.2× 36 1.1k
Zongliu Hou China 19 445 1.2× 284 1.0× 169 0.7× 184 0.7× 194 0.9× 59 993
Sunish Mohanan United States 14 490 1.3× 481 1.6× 150 0.6× 305 1.2× 228 1.1× 24 1.3k
Shiv K. Singh Germany 19 766 2.1× 629 2.2× 163 0.6× 274 1.1× 245 1.2× 33 1.5k
Sophia K. Khaldoyanidi United States 24 788 2.2× 389 1.3× 223 0.9× 509 2.0× 151 0.7× 50 1.7k
Dorota Jesionek‐Kupnicka Poland 17 308 0.8× 216 0.7× 195 0.8× 149 0.6× 168 0.8× 96 931
Daniel R. Boué United States 18 633 1.7× 123 0.4× 192 0.8× 133 0.5× 102 0.5× 57 1.2k
Majid Shahbazi Iran 13 463 1.3× 271 0.9× 58 0.2× 227 0.9× 161 0.8× 72 1.1k
Alessandra Castiglioni United States 10 669 1.8× 475 1.6× 157 0.6× 480 1.9× 165 0.8× 16 1.4k

Countries citing papers authored by Hao Duan

Since Specialization
Citations

This map shows the geographic impact of Hao Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Duan more than expected).

Fields of papers citing papers by Hao Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Duan. The network helps show where Hao Duan may publish in the future.

Co-authorship network of co-authors of Hao Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Duan. A scholar is included among the top collaborators of Hao Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Duan. Hao Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, You, Qi Li, Hao Duan, et al.. (2025). ELISA protein detector (EPD): A Python-based ELISA tool for accurate low-level protein quantification. Journal of Immunological Methods. 539. 113847–113847.
2.
Wang, Xiaofei, Hao Duan, Wanming Hu, et al.. (2025). Joint modeling histology and molecular markers for cancer classification. Medical Image Analysis. 102. 103505–103505.
3.
4.
Xie, Duo, Wen‐Fang Tang, Tao Jiang, et al.. (2025). Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases. Cell Reports. 44(10). 116449–116449.
5.
Duan, Hao, Zhenqiang He, Yukun Chen, et al.. (2024). Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. BMC Immunology. 25(1). 83–83.
6.
Duan, Hao, Qingchen Zhang, Feifei Cui, Quan Zou, & Zilong Zhang. (2024). MVST: Identifying spatial domains of spatial transcriptomes from multiple views using multi-view graph convolutional networks. PLoS Computational Biology. 20(9). e1012409–e1012409. 5 indexed citations
7.
Wang, Zhenning, Zhenqiang He, Yang Hu, et al.. (2023). Oligomer‐Aβ42 suppress glioma progression via potentiating phagocytosis of microglia. CNS Neuroscience & Therapeutics. 30(1). e14495–e14495. 2 indexed citations
8.
Duan, Hao, Yuheng Zou, Jing Wang, et al.. (2023). Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. Phytomedicine. 114. 154764–154764. 13 indexed citations
9.
Huang, Menggui, Fan Yang, Duo Zhang, et al.. (2022). Endothelial plasticity drives aberrant vascularization and impedes cardiac repair after myocardial infarction. Nature Cardiovascular Research. 1(4). 372–388. 13 indexed citations
10.
Li, Chang, Sheng Zhong, Hao Duan, et al.. (2022). The application of fluorescein sodium for the resection of medulloblastoma. Journal of Neuro-Oncology. 158(3). 463–470. 12 indexed citations
11.
Zhong, Sheng, Jiaxin Ren, Davy Deng, et al.. (2022). Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics. Journal of neurosurgery. 139(2). 305–314. 17 indexed citations
12.
Wang, Zhenning, Xiaobing Jiang, Jie Lü, et al.. (2022). Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study. Annals of Surgical Oncology. 29(6). 3684–3693. 4 indexed citations
13.
Yang, Fan, Zhenqiang He, Hao Duan, et al.. (2021). Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nature Communications. 12(1). 3424–3424. 114 indexed citations
14.
Li, De‐Pei, Wanming Hu, Xiaoping Lin, et al.. (2021). CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas. Frontiers in Cell and Developmental Biology. 9. 653240–653240. 2 indexed citations
15.
Yang, Guang, et al.. (2020). <p>lncRNA FLVCR-AS1 promotes osteosarcoma growth by targeting miR381-3p/CCND1</p>. OncoTargets and Therapy. Volume 13. 163–172. 12 indexed citations
16.
Ma, Wenjuan, Hao Duan, Rongxin Zhang, et al.. (2019). High Expression of Indoleamine 2, 3-Dioxygenase in Adenosquamous Lung Carcinoma Correlates with Favorable Patient Outcome. Journal of Cancer. 10(1). 267–276. 12 indexed citations
17.
Duan, Hao, Zhenqiang He, Chengcheng Guo, et al.. (2018). Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment. Cancer Management and Research. Volume 10. 2467–2474. 3 indexed citations
18.
Wang, Yang, Ji Zhang, Fuhua Lin, et al.. (2018). Outcome and prognostic value of treatment for brain metastases and the primary tumor in patients with breast cancer brain metastases. Clinical Neurology and Neurosurgery. 170. 43–46. 3 indexed citations
19.
Xie, Bing, Chao Xu, Qing Xiong, et al.. (2016). Gene sequencing and variable site analyzing of coding region of two enterovirus A71 isolates with different clinical phenotypes. Infection Genetics and Evolution. 45. 83–89. 2 indexed citations
20.
Gao, Meng, Hao Duan, Jing Liu, et al.. (2014). The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins. Antiviral Research. 106. 80–85. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryosuke Uchibori Breakdown of academic impact, for papers by Dejun Gong Breakdown of academic impact, for papers by Zongliu Hou Breakdown of academic impact, for papers by Sunish Mohanan Breakdown of academic impact, for papers by Shiv K. Singh Breakdown of academic impact, for papers by Sophia K. Khaldoyanidi Breakdown of academic impact, for papers by Dorota Jesionek‐Kupnicka Breakdown of academic impact, for papers by Daniel R. Boué Breakdown of academic impact, for papers by Majid Shahbazi Breakdown of academic impact, for papers by Alessandra Castiglioni
Rankless by CCL
2026